Wei Shuhui, Zhang Hong, Tao Shasha
School of Public Health , Medical College of Soochow University , 199 Ren'ai Road , Suzhou 215123 , Jiangsu , China . Email:
Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Disease , School of Public Health , Soochow University , Suzhou , 215123 , PR China.
Toxicol Res (Camb). 2019 Jan 23;8(3):319-327. doi: 10.1039/c8tx00298c. eCollection 2019 May 1.
As a well-established human carcinogen, arsenic has increased the risk of lung cancer over the past decades. Wide exposure to arsenic in the environment has attracted the attention of scientists. Its carcinogenicity at early life stages has been observed in certain animal studies already, yet current evidence is insufficient to extrapolate this to humans. Although the mechanisms of lung cancer induced by arsenic remain unclear, most of them are related to the biotransformation of arsenic, which would further provide target sites for precaution and therapy. This review comprehensively summarizes current studies associated to arsenic exposure and lung cancer and the mechanism of its carcinogenesis in lung cancer in three sections, namely, epidemiological studies, experimental studies, and mechanistic studies. In addition, prevention and treatment strategies as well as directions for future studies are discussed.
作为一种公认的人类致癌物,砷在过去几十年里增加了肺癌风险。环境中砷的广泛暴露已引起科学家的关注。在某些动物研究中已观察到其在生命早期阶段的致癌性,但目前的证据不足以将此推断至人类。尽管砷诱发肺癌的机制尚不清楚,但大多数机制与砷的生物转化有关,这将进一步为预防和治疗提供靶点。本综述在流行病学研究、实验研究和机制研究三个部分全面总结了当前与砷暴露和肺癌相关的研究及其在肺癌中的致癌机制。此外,还讨论了预防和治疗策略以及未来研究方向。